longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Rennova Health, Inc.

RNVA

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 0.00, within the reasonable range, cheaper than 96.04% of the time in the past 3 years, and the industry ranks 1/23, the industry Median 13.51.

0.0021xP/E
$0.00Stock price
0.0021xP/E
Stock price$0.00

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
0.00x
Typical range
0.00x–0.00x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 13.51x
05101520

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 13.51x
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BKDUSBrookdale Senior Living
-20.96x102.39%$2.90B
ACHCUSAcadia Healthcare
-2.34x107.17%$2.64B
SNDAUSSonida Senior Living
-13.06x14.93%$1.90B
SGRYUSSurgery Partners
-21.25x52.21%$1.88B
STLNUSStarling Oncology
-20.57x70.00%$628.82M
IVPRUSInspire Veterinary Partners, Inc.
-0.00x--$44.88K
RNVAUSRennova Health, Inc.
----$40.55K

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.